Izokibep (Partnered)

About Affibody

Affibody is a clinical-stage biotech pioneering a new generation of targeted radioligand therapies (RLTs) for oncology using its proprietary Affibody® molecule platform. The company's strategy focuses on targets and cancer indications with high unmet need where its small, engineered protein scaffolds offer potential competitive advantages in tumor penetration and clearance. Beyond its core oncology pipeline, Affibody generates value through partnership programs in immunology and has established key collaborations for radiopharmaceutical supply and development. With a strong scientific foundation, a deep pipeline, and a seasoned team, Affibody is positioned as a notable player in the expanding radiopharmaceutical therapeutics field.

Therapeutic Areas

Other Hidradenitis Suppurativa (HS) Drugs